Cancer screening resident survival guide: Difference between revisions
Jump to navigation
Jump to search
TayyabaAli (talk | contribs) |
TayyabaAli (talk | contribs) |
||
| Line 21: | Line 21: | ||
*According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, [[Lung cancer]] is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths).<ref name="pmid30207593">{{cite journal| author=Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A| title=Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | journal=CA Cancer J Clin | year= 2018 | volume= 68 | issue= 6 | pages= 394-424 | pmid=30207593 | doi=10.3322/caac.21492 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30207593 }} </ref> | *According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, [[Lung cancer]] is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths).<ref name="pmid30207593">{{cite journal| author=Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A| title=Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | journal=CA Cancer J Clin | year= 2018 | volume= 68 | issue= 6 | pages= 394-424 | pmid=30207593 | doi=10.3322/caac.21492 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30207593 }} </ref> | ||
Recommendations for lung cancer screening:<ref name="urlRecommendation: Lung Cancer: Screening | United States Preventive Services Taskforce">{{cite web |url=https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening |title=Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforce |format= |work= |accessdate=8/3/2020}}</ref> | '''Recommendations for lung cancer screening:'''<ref name="urlRecommendation: Lung Cancer: Screening | United States Preventive Services Taskforce">{{cite web |url=https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening |title=Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforce |format= |work= |accessdate=8/3/2020}}</ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align=center | ||
|+ | |+ | ||
Revision as of 17:55, 3 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]
Overview
This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.
Common Cancers
Breast Cancer
- Breast cancer screening starts at age ..... via [imaging].
- To view the detailed information on breast cancer screening click here.
Cervical Cancer
Colorectal Cancer
- Colorectal cancer screening starts among asymptomatic adults at the age of 50 with no family history of adenoma or colorectal cancer. It is preferably done via colonoscopy[1]
- According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, Colon cancer is the fourth commonly occurring cancer (6.1% for incidence). It is the third cause of death in cancer patients (9.2% for mortality).[2]
- To view the detailed information on colorectal cancer screening click here.
Endometrial Cancer
Esophageal Cancer
Lung Cancer
- Lung cancer screening starts among asymptomatic adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit smoking within the past 15 years.[3]
- According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, Lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths).[2]
Recommendations for lung cancer screening:[3]
| Recommended test |
|
| Recommended Interval |
|
| Age for screening |
|
| Eligibility for screening based on smoking history |
|
| Discontinuation of screening |
|
- To view the detailed information on Lung cancer screening click here.
Ovarian cancer
Prostate Cancer
- ↑ US Preventive Services Task Force. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW; et al. (2016). "Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement". JAMA. 315 (23): 2564–2575. doi:10.1001/jama.2016.5989. PMID 27304597.
- ↑ 2.0 2.1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018). "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries". CA Cancer J Clin. 68 (6): 394–424. doi:10.3322/caac.21492. PMID 30207593.
- ↑ 3.0 3.1 "Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforce". Retrieved 8/3/2020. Check date values in:
|accessdate=(help)